Agios Pharmaceuticals (AGIO) Stock Highlights

54.62 | +0.39%

2024-11-21 02:17:26

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The companys primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Statistics

Range Today

53.82 55.3

Volume Today 367.12K

Range 1 Year

20.96 62.58

Volume 1 Year 171.42M

Range 3 Year

16.75 62.58

Volume 3 Year 458.8M

Range 10 Year

16.75 138.85

Volume 10 Year 1.58B

Highlights

Market Capitalization 3.37B (mid)

Floating Shares 50.51M

Current Price 54.62

Price To Earnings 4.35

Price To Revenue 73.75

Price To Book 2.07

Earnings Per Share 12.5

Payout Ratio 0%

Performance

Latest +0.39%

1 Month +20.2%

3 Months +20.28%

6 Months +59.01%

1 Year +145.59%

3 Years +42.57%

5 Years +50.59%

10 Years -41.99%

Benchmarks

Market Capitalization

83 / 368

Gross Profits

96 / 278

Total Revenue

153 / 300

Total Rank

284 / 368

Free Cashflow

324 / 352

Performance 5 years

88 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.